Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

General (Details)

v3.20.1
General (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 16, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
General (Textual)        
Deferred payments $ 5,000      
Accrued milestone payments 175      
Capital gain amount $ 769      
Net losses   $ (12,625) $ (6,571) $ (4,842)
Negative cash flows from operatingactivities   (10,834) (4,155) (8,972)
Decrease in operating lease right of use assets   1    
Decrease in finance expenses   3    
Increase in general and administrative expense   4    
Decrease in finance income   3,037    
Increase in finance income       $ 1,591
Increase (decrease) in additional paid-in capital   1,666 (2,937)  
Increase in shareholders’ equity   1,565    
Increase (decrease) in retained earnings (deficit)   $ 101 $ (2,937)  
Conversion of American Depositary Shares   10    
Ophthalix, Inc [Member]        
General (Textual)        
Ownership interest percentage 8.00% 82.00%